<DOC>
	<DOCNO>NCT02364869</DOCNO>
	<brief_summary>This 12-week double-blind randomize control clinical trial aim investigate effect prebiotic ( fructooligosaccharide - FOS ) serum urinary level uremic toxin ( p-cresyl sulfate indoxyl sulfate ) non-dialysis dependent CKD patient , impact intervention cardiovascular marker , intestinal permeability , endotoxemia inflammatory response .</brief_summary>
	<brief_title>Prebiotic Chronic Kidney Disease Patients</brief_title>
	<detailed_description>Intestinal microbiome consider new therapeutic target chronic kidney disease ( CKD ) due potential role metabolic disturbance associate disease . The abnormality microbiota , frequently find patient CKD , contribute accumulation uremic toxin derive unbalanced fermentation nitrogen compound relation non-digestible carbohydrate . Among , p-cresyl sulfate indoxyl sulfate associate inflammation , kidney disease progression , endothelial dysfunction increase risk death population . Preliminary study especially hemodialysis show use prebiotic , probiotic symbiotic may represent promise intervention due beneficial effect modulators intestinal microbiota might promote reduction serum concentration p-cresyl sulfate indoxyl sulfate . In comparison probiotic , prebiotic advantage stimulate host 's microbiota occur naturally several food . In context CKD , use prebiotics poorly investigate . Therefore , primary aim study investigate effect prebiotic ( fructooligosaccharide - FOS ) serum urinary level p-cresyl sulfate indoxyl sulfate non-dialysis dependent CKD patient . As secondary aim investigate impact intervention cardiovascular marker , intestinal permeability , endotoxemia inflammatory response . This 12-week double-blind randomize control clinical trial . Fifty non-diabetic patient CKD stag 3a 4 randomly assign 12 g/day FOS maltodextrin ( placebo ) . The serum urinary concentration p-cresyl sulfate indoxyl sulfate determine high performance liquid chromatography ( HPLC ) . The assessment endothelial function include ultrasonography brachial artery , measurement plasma urinary nitric oxide , monocyte chemoattractant protein 1 ( MCP1 ) , stromal cell-derived factor 1 alpha ( SDF1α ) , oxide - trimethylamine N- ( TMAO ) , ambulatory blood pressure monitoring ( ABPM ) pulse wave velocity ( PWV ) . The serum intestinal trophic marker ( glucagon-like peptide 2 - GLP2 - epidermal growth factor - EGF ) , intestinal permeability ( Zonulin ) , endotoxemia inflammation ( IL-6 CRP ) determine ELISA . Food intake assess 3-day food record . Protein intake estimate calculate protein equivalent nitrogen appearance ( PNA ) . The Bristol Scale , Roma III Criteria Gastrointestinal Symptoms Rating Scale apply evaluate gastrointestinal effect follow-up . The subjective global assessment questionnaire , spectroscopic bioimpedance analysis handgrip strength apply evaluate nutritional status patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>18 80 year Estimated glomerular filtration rate 45 15 ml/min/1,73m² . diabetes mellitus , malignance , severe liver disease , autoimmune disease , congestive heart failure class III / IV , HIV , history gastrointestinal disease use phosphate binder , laxatives prebiotic , probiotic , symbiotic , antibiotic , immunosuppressant / antiinflammatory drug three month precede study . patient use laxative refuse stop treatment followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>P-cresyl sulfate</keyword>
	<keyword>Indoxyl sulfate</keyword>
	<keyword>Intestine</keyword>
	<keyword>Endothelial function</keyword>
</DOC>